Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  189 results for ""Glucagon-Like Peptides""

Your Filters

Publisher : mdpi
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A Systematic Review of Semaglutide's Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies.

  • Authors : Tipa RO; Department of Psychiatry, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.; 'Prof. Dr. Alexandru Obregia' Clinical Psychiatric Hospital, 041914 Bucharest, Romania.

Subjects: Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/pharmacology ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Cognition*/Cognition*/Cognition*/drug effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 02; Vol. 25 (9). Date of Electronic Publication: 2024 May 02.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Assessment of Thyroid Carcinogenic Risk and Safety Profile of GLP1-RA Semaglutide (Ozempic) Therapy for Diabetes Mellitus and Obesity: A Systematic Literature Review.

  • Authors : Feier CVI; First Discipline of Surgery, Department X-Surgery, 'Victor Babes' University of Medicine and Pharmacy, 2 E. Murgu Sq., 300041 Timisoara, Romania.; First Surgery Clinic, 'Pius Brinzeu' Clinical Emergency Hospital, 300723 Timisoara, Romania.

Subjects: Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/adverse effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Apr 15; Vol. 25 (8). Date of Electronic Publication: 2024 Apr 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.

  • Authors : Soto-Catalán M; Renal, Vascular and Diabetes Research Laboratory, IIS-Fundación Jiménez Díaz, Spanish Biomedical Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), 28029 Madrid, Spain.

Subjects: Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/Diabetes Mellitus, Experimental*/metabolism ; Fatty Liver*/Fatty Liver*/Fatty Liver*/metabolism ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 04; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Semaglutide Modulates Extracellular Matrix Production of LX-2 Cells via Exosomes and Improves Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

  • Authors : Scavo MP; Laboratory of Personalized Medicine, National Institute of Gastroenterology, IRCCS DeBellis, 70013 Castellana Grotte, BA, Italy.; Lisco G

Subjects: Exosomes* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 25; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes?

  • Authors : Kim HS; Asan Medical Center, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul 05505, Korea.; Asan Diabetes Center, Asan Medical Center, Seoul 05505, Korea.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*agonists ; Glucagon-Like Peptides/Glucagon-Like Peptides/Glucagon-Like Peptides/*administration & dosage

  • Source: International journal of molecular sciences [Int J Mol Sci] 2021 Sep 14; Vol. 22 (18). Date of Electronic Publication: 2021 Sep 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System.

  • Authors : Chiou HC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung City 807, Taiwan. .; Lin MW

Subjects: Central Nervous System/Central Nervous System/Central Nervous System/*pathology ; Encephalomyelitis, Autoimmune, Experimental/Encephalomyelitis, Autoimmune, Experimental/Encephalomyelitis, Autoimmune, Experimental/*drug therapy ; Encephalomyelitis, Autoimmune, Experimental/Encephalomyelitis, Autoimmune, Experimental/Encephalomyelitis, Autoimmune, Experimental/*immunology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2019 Mar 29; Vol. 20 (7). Date of Electronic Publication: 2019 Mar 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Role of SGLT2 Inhibitors, DPP-4 Inhibitors, and Metformin in Pancreatic Cancer Prevention.

Subjects: METFORMIN; ENZYME inhibitors; CELL proliferation

  • Source: Cancers; Apr2024, Vol. 16 Issue 7, p1325, 15p

Record details

Read More Add to Saved list
×
Academic Journal

Substance P and Glucagon-like Peptide-1 7-36 Amide Mediate Anorexic Responses to Trichothecene Deoxynivalenol and Its Congeners.

Subjects: SUBSTANCE P; NEUROPEPTIDES; ORAL drug administration

  • Source: Toxins; Dec2022, Vol. 14 Issue 12, p885, 14p

Record details

Read More Add to Saved list
×
Academic Journal

Systematic Review and Meta-Analysis of the Efficacy and Safety of Metformin and GLP-1 Analogues in Children and Adolescents with Diabetes Mellitus Type 2.

Subjects: DRUG efficacy; ONLINE information services; MEDICAL databases

  • Source: Children; Oct2022, Vol. 9 Issue 10, p1572-N.PAG, 11p

Record details

Read More Add to Saved list
×
Academic Journal

Regulatory Mechanisms of Somatostatin Expression.

Subjects: *SOMATOSTATIN; *GLUCAGON-like peptides; *CENTRAL nervous system

  • Source: International Journal of Molecular Sciences. Jun2020, Vol. 21 Issue 11, p4170-4170. 1p.

Record details

Read More Add to Saved list
×
  • 1-10 of  189 results for ""Glucagon-Like Peptides""